ResMed Story Overview

RMD -- USA Stock  

USD 113.83  2.04  1.82%

Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
Exercise or conversion by Brett Sandercock of 5000 shares of ResMed subject to Rule 16b-3
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

ResMed Inc insider trading alert for exercise of resmed nq stock options by Brett Sandercock, Chief Financial Officer, on December 23, 2017. This event was filed by Resmed Inc with SEC on 2013-08-29. Statement of changes in beneficial ownership - SEC Form 4. Brett Sandercock is currently serves as cfo and principal accounting officer of ResMed Inc

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for ResMed

a day ago at www.macroaxis.com 
Acquisition by David Pendarvis of 5168 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
few days ago at www.macroaxis.com 
Sale by Brett Sandercock of 2000 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over a week ago at http://www.mareainformativa.com 
US Bancorp DE Reduces Position in ResMed Inc.
news
Marea Informative Full coverage
over a week ago at http://www.fool.com.au 
How Im preparing for the next financial crisis
fool News
Motley Fool AustraliaFull coverage
over two weeks ago at www.macroaxis.com 
Sale by Hollingshead James of 600 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over three weeks ago at http://www.wallstreetinvestorplace.com 
Low-Risky stock to Watch ResMed Inc.
news
Wallstreet InvestorplaceFull coverage
over three weeks ago at www.macroaxis.com 
Sale by Brett Sandercock of 2000 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over a month ago at http://cedarvillenews.com 
Putting ResMed Inc Under the Microscope Stock Ticks -0.13
news
Cedarville NewsFull coverage
over a month ago at www.macroaxis.com 
Acquisition by Richard McHale of 7296 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at http://simplywall.st 
What Should You Know About ResMed Incs Future
news
Simply Wall StHodges Capital Management Trimmed Its Gogo Position Bank Of Nova Scotia Has Trimmed Resmed Long or Short ResMed TNNFull coverage
over a month ago at www.macroaxis.com 
Exercise or conversion by David Pendarvis of 2810 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over two months ago at http://carthagestandard.com 
What Kind of Picture Are the Technicals Painting For ResMed Inc Shares Tick -0.21
news
Carthage StandardWhy ResMed Inc. Is Being Added to Investors Watchlist StockNewsGazetteFull coverage
over three months ago at http://danversrecord.com 
Resmed Inc Heading in the Right Direction
news
Danvers RecordFull coverage

EBITDA

EBITDA Comparative Analysis

  EBITDA 
      ResMed Comparables 
ResMed is rated below average in ebitda category among related companies. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Peers

ResMed Related Equities

RMD  1.82 %   
0%
74.0%
EW  1.46 %   
0%
59.0%
SYK  0.89 %   
0%
36.0%
VAR  0.72 %   
0%
29.0%
A  0.58 %   
0%
23.0%
CI  0.45 %   
0%
18.0%
XRAY  0.39 %   
0%
15.0%
TFX  0.1 %   
4.0%
0%
CO  2.45 %   
100.0%
0%
Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Search macroaxis.com